What happened in biosimilars during 2014

posted 06/03/2015

Many new developments have taken place in the biosimilars industry in 2014 [1]. One of the most important milestones during 2014 was the news that the US Foo...

Poor generics awareness among physicians in Sau... Generics/Research | Posted 06/03/2015
Hospira launches infliximab biosimilar in major... Biosimilars/News | Posted 06/03/2015
EMA’s clinical transparency rules come under fire Policies & Legislation | Posted 06/03/2015
FDA cash to develop hard-to-copy generics Generics/General | Posted 06/03/2015
Comparison of non-originator filgrastim with Ne... Biosimilars/Research | Posted 06/03/2015
US court invalidates asthma drug patent Generics/News | Posted 06/03/2015
FDA delays meeting to evaluate infliximab biosi... Biosimilars/News | Posted 27/02/2015
Biosimilars of rituximab Biosimilars/General | Posted 27/02/2015
Pfizer warns UK doctors not to prescribe generi... Generics/General | Posted 27/02/2015
FDA re-opens comment period on generics labelli... Policies & Legislation | Posted 27/02/2015
Accord launches biosimilar filgrastim in Europe Biosimilars/News | Posted 27/02/2015
Actavis receives generic opioid approval and pl... Generics/News | Posted 27/02/2015
World Biosimilar Congress USA 2015 Conferences | Posted 27/02/2015
Generics and off-patent biologicals for cancer... Biosimilars/Research | Posted 20/02/2015
Substitution and adherence to antidiabetic gene... Generics/Research | Posted 20/02/2015
Positive phase III data for Amgen adalimumab bi... Biosimilars/Research | Posted 20/02/2015
Hospira and Pfenex to collaborate on ranibizuma... Biosimilars/News | Posted 20/02/2015
Mylan being sued over sorafenib generic Generics/News | Posted 20/02/2015
Biosimilars compared to generics in the Europea... Biosimilars/Research | Posted 13/02/2015
FDA advisers to consider infliximab biosimilar Biosimilars/News | Posted 13/02/2015
EMA explains redaction of AbbVie’s data Policies & Legislation | Posted 13/02/2015
Biosimilars of infliximab Biosimilars/General | Posted 13/02/2015
Torrent licenses three ‘similar biologics’ from... Biosimilars/News | Posted 13/02/2015
US pay-for-delay deals decrease in 2013 Reports | Posted 13/02/2015
Generics versus brand-name drugs Generics/Research | Posted 06/02/2015
Impact of nephrology subsequent entry biologics... Biosimilars/Research | Posted 06/02/2015
Hanwha to transfer biosimilar etanercept techno... Biosimilars/News | Posted 06/02/2015
EMA recommends suspending generics from GVK Bio Policies & Legislation | Posted 06/02/2015
Actavis to buy UK generics maker Auden McKenzie Pharma News | Posted 06/02/2015
Akorn submits ANDA for difluprednate ophthalmic... Generics/News | Posted 06/02/2015
Irish doctors’ attitudes towards generics Generics/Research | Posted 30/01/2015
Japanese approval for insulin glargine biosimilar Biosimilars/News | Posted 30/01/2015
No relevant difference in ADRs from biosimilars... Biosimilars/Research | Posted 30/01/2015
EMA to collaborate with other agencies on generics Policies & Legislation | Posted 30/01/2015
Biosimilars applications under review by EMA –... Biosimilars/General | Posted 30/01/2015
FDA approves first generic esomeprazole Generics/News | Posted 30/01/2015
Adalimumab similar biologic launched in India Biosimilars/News | Posted 30/01/2015
11th EGA Legal Affairs Forum Conferences | Posted 30/01/2015

Generics News Research General


Biosimilars News Research General